Order Article Reprints

Chia S, Gandhi S, Joy AA, Edwards S, Gorr M, Hopkins S, Kondejewski J, Ayoub JP, Califaretti N, Rayson D, et al. Novel Agents and Associated Toxicities of Inhibitors of the PI3K/Akt/mTOR Pathway for the Treatment of Breast Cancer. Current Oncology. 2015; 22(1):33-48. https://doi.org/10.3747/co.22.2393

Chia, S., S. Gandhi, A.A. Joy, S. Edwards, M. Gorr, S. Hopkins, J. Kondejewski, J.P. Ayoub, N. Califaretti, D. Rayson, and et al. 2015. "Novel Agents and Associated Toxicities of Inhibitors of the PI3K/Akt/mTOR Pathway for the Treatment of Breast Cancer" Current Oncology 22, no. 1: 33-48. https://doi.org/10.3747/co.22.2393

Chia, S., Gandhi, S., Joy, A. A., Edwards, S., Gorr, M., Hopkins, S., Kondejewski, J., Ayoub, J. P., Califaretti, N., Rayson, D., & Dent, S. F. (2015). Novel Agents and Associated Toxicities of Inhibitors of the PI3K/Akt/mTOR Pathway for the Treatment of Breast Cancer. Current Oncology, 22(1), 33-48. https://doi.org/10.3747/co.22.2393